Poland· PL-100305096
Metex PEN
A methotrexate product containing methotrexatum, registered in Poland by medac Gesellschaft fuer klinische Spezialpraeparate mbH. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Methotrexate is registered in 12 of 19 countries.
Countries holding a registration under ATC L01BA01 (methotrexate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Methotrexate · ATC L01BA01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Methotrexatum
- Manufacturer
- medac Gesellschaft fuer klinische Spezialpraeparate mbH
- Country
- Poland (PL)
- ATC code
- L01BA01
- ATC class
- Methotrexate
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 11
- gtin05909991091644
- gtin05909991091651
- gtin05909991091668
- gtin05909991091675
- gtin05909991091682
- gtin05909991091699
- gtin05909991091705
- gtin05909991091743
- gtin05909991091750
- gtin05909991091767
- gtin05909991091774
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
949 interactions on record for methotrexate.
Graded by severity as the source publishes them — 107 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methotrexate · interactions on record
949 records
- 107 severe
- 466 moderate
- 17 minor
- 309 info
Most severe, free to view
- OmeprazoleA02BC01severe
- PantoprazoleA02BC02severe
- LansoprazoleA02BC03severe
- RabeprazoleA02BC04severe
50 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methotrexate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaINJEXATE AUTOINJEKTORACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- SwedenInjexate 30 mg Injektionsvätska, lösning i förfylld injektorAccord Healthcare B.V.
- SwitzerlandMetoject 30 mg, InjektionslösungGebro Pharma AG
- BelgiumBasitrin 30 mgBasic Pharma Manufacturing
- NorwayMetexMedac - Gesellschaft für klinische Spezialpräparate Gmbh - Wedel
- SpainMETOJECT PEN 30 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAMedac Gesellschaft Für Klinische Spezialpräparate Gmbh
- IcelandMetojectpenmedac Gesellschaft für klinische Spezialpräparate GmbH
- United KingdomEbetrex 10mg/1ml solution for injection pre-filled syringesSandoz Ltd
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ebetrexat, Methofill
- Belgium · Basitrin, Emthexate
- Bulgaria · Ebetrexat, Инжексат
- Cyprus · Injexate, Methotrexate Accord
- Czechia · Foxiemo, Injexate
- Germany · Lantarel, Lantarel Fs
- Denmark · Ebetrex, Emthexate
- Estonia · Ebetrex, Metex
- Spain · Bertanel, Imeth
- Finland · Ebetrex, Injexate
- France · Imenor, Imeth
- United Kingdom (Northern Ireland) · Ebetrex, Injexate
- Greece · Methobion, Methotrexate Pfizer
- Croatia · Ebetrexat, Methofill
- Hungary · Ebetrexat, Methofill
- Ireland · Methofill, Methotrexate Abcur
- Iceland · Jylamvo, Methotrexat Ebewe
- Italy · Afslamet, Immutrex
- Liechtenstein · Jylamvo, Nordimet
- Lithuania · Ebetrexat, Metex
- Luxembourg · Emthexate, Emthexate Teva Pharma
- Latvia · Ebetrex, Metex
- Malta · Methotrexate Aspire Pharma (Malta)
- Netherlands · Basitrin, Ebetrex
- Norway · Ebetrex, Jylamvo
- Portugal · Fauldexato, Ledertrexato
- Romania · Methotrexat Ebewe, Metorthrit
- Sweden · Ebetrex, Injexate
- Slovenia · Methofill, Metoject
- Slovakia · Foxiemo, Injexate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdd9ad88-91ba-47d5-9d28-27bd8aebc32d GET /v1/drugs/cdd9ad88-91ba-47d5-9d28-27bd8aebc32d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań we wstrzykiwaczu",
"source": "urpl",
"strength": "30 mg",
"packaging": "05909991091644 ¦ Rp ¦ 87163\n1 wstrzyk. 0,6 ml\n05909991091651 ¦ Rp ¦ 87164\n2 wstrzyk. 0,6 ml\n05909991091668 ¦ Rp ¦ 87165\n4 wstrzyk. 0,6 ml\n05909991091675 ¦ Rp ¦ 87166\n5 wstrzyk. 0,6 ml\n05909991091682 ¦ Rp ¦ 87167\n6 wstrzyk. 0,6 ml\n05909991091699 ¦ Rp ¦ 87168\n10 wstrzyk. 0,6 ml\n05909991091705 ¦ Rp ¦ 87169\n11 wstrzyk. 0,6 ml\n05909991091743 ¦ Rp ¦ 87170\n12 wstrzyk. 0,6 ml\n05909991091750 ¦ Rp ¦ 87171\n14 wstrzyk. 0,6 ml\n05909991091767 ¦ Rp ¦ 87172\n15 wstrzyk. 0,6 ml\n05909991091774 ¦ Rp ¦ 87173\n24 wstrzyk. 0,6 ml",
"substance": "Methotrexatum natricum 30 mg",
"common_name": "Methotrexatum",
"pl_product_id": "100305096",
"pozwolenie_nr": "21543",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about methotrexate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.